tiprankstipranks
Trending News
More News >
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market

Coya Therapeutics, Inc. (COYA) Income Statement

Compare
103 Followers

Coya Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), Coya Therapeutics, Inc.'s total revenue was $3.56M, an increase of Infinity% from the same quarter last year. In Q3, Coya Therapeutics, Inc.'s net income was $-2.12M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.55M$ 6.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -8.31M$ 500.68K$ -4.41M$ 0.00$ 0.00
Operating Expenses
$ 8.94M$ 8.40M$ 5.40M$ 4.87M$ 1.04M
Depreciation and Amortization
$ 27.36K$ 27.36K$ 27.36K$ 16.13K$ 704.65K
EBITDA
$ -17.20M$ -7.33M$ -9.26M$ -4.85M$ 0.00
Operating Income
$ -17.25M$ -7.90M$ -9.81M$ -4.87M$ -1.04M
Other Income/Expenses
$ 1.65M$ 639.37K$ -2.43M$ -21.48K$ -57.64K
Pretax Income
$ -15.60M$ -7.26M$ -12.24M$ -4.89M$ -1.10M
Net Income
$ -14.88M$ -7.99M$ -12.24M$ -4.89M$ -1.10M
Per Share Metrics
Basic EPS
$ -0.98$ -0.79$ -1.23$ -0.74$ -0.42
Diluted EPS
$ -0.98$ -0.79$ -1.23$ -0.74$ -0.42
Weighted Average Shares Outstanding
15.24M 10.16M 9.95M 6.60M 2.59M
Weighted Average Shares Outstanding (Diluted)
15.24M 10.16M 9.95M 6.60M 2.59M
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History